Proactive familial cancer risk assessment: a service development study in UK primary care.

early detection of cancer general practitioners medical history taking primary health care

Journal

BJGP open
ISSN: 2398-3795
Titre abrégé: BJGP Open
Pays: England
ID NLM: 101713531

Informations de publication

Date de publication:
12 Dec 2023
Historique:
received: 28 04 2023
revised: 31 07 2023
accepted: 11 08 2023
pubmed: 18 8 2023
medline: 18 8 2023
entrez: 17 8 2023
Statut: aheadofprint

Résumé

Family history assessment can identify individuals above population-risk for cancer to enable targeted Screening, Prevention, and Early Detection (SPED). Family History Questionnaire Service (FHQS) is a resource-efficient patient-facing online tool to facilitate this. In the UK, cancer risk assessment is usually only offered to concerned individuals proactively self-presenting to their GP, leading to inequity in accessing SPED in the community. To improve access to community cancer genetic risk assessment and explore barriers to uptake. Service development project of a digital pathway using the FHQS for cancer risk assessment across four general practices within the clinical remit of the South West Thames Centre for Genomics (SWTCG). 3100 individuals aged 38-50 years were invited to complete the FHQS through either text message or email. A random selection of 100 non-responders were contacted to determine barriers to uptake. In total, The FHQS can be used as part of a low-resource primary care pathway to identify individuals in the community above population-risk for cancer requiring action. This study highlighted barriers to uptake requiring consideration to maximise impact and minimise inequity.

Sections du résumé

BACKGROUND BACKGROUND
Family history assessment can identify individuals above population-risk for cancer to enable targeted Screening, Prevention, and Early Detection (SPED). Family History Questionnaire Service (FHQS) is a resource-efficient patient-facing online tool to facilitate this. In the UK, cancer risk assessment is usually only offered to concerned individuals proactively self-presenting to their GP, leading to inequity in accessing SPED in the community.
AIM OBJECTIVE
To improve access to community cancer genetic risk assessment and explore barriers to uptake.
DESIGN & SETTING METHODS
Service development project of a digital pathway using the FHQS for cancer risk assessment across four general practices within the clinical remit of the South West Thames Centre for Genomics (SWTCG).
METHOD METHODS
3100 individuals aged 38-50 years were invited to complete the FHQS through either text message or email. A random selection of 100 non-responders were contacted to determine barriers to uptake.
RESULTS RESULTS
In total,
CONCLUSION CONCLUSIONS
The FHQS can be used as part of a low-resource primary care pathway to identify individuals in the community above population-risk for cancer requiring action. This study highlighted barriers to uptake requiring consideration to maximise impact and minimise inequity.

Identifiants

pubmed: 37591554
pii: BJGPO.2023.0076
doi: 10.3399/BJGPO.2023.0076
pii:
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

Copyright © 2023, The Authors.

Auteurs

Abdul Rahman Badran (AR)

South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, UK abdul.badran@nhs.net.
Fieldway Medical Centre, Danebury, New Addington, Croydon, UK.

Alice Youngs (A)

South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, UK.

Andrea Forman (A)

South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, UK.

Marisa Elms (M)

South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, UK.

Lai-Lai Chang (LL)

West Barnes Surgery, West Barnes Lane, London, UK.

Fiyaz Lebbe (F)

Fieldway Medical Centre, Danebury, New Addington, Croydon, UK.

Adam Reekie (A)

South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, UK.

John Short (J)

South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, UK.

Min Theik Hlaing (MT)

South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, UK.

Emma Watts (E)

Shere Surgery, Gomshall Lane, Guildford, UK.

Deborah Hipps (D)

The Exchange Surgery, Gracefield Gardens, London, UK.

Katie Snape (K)

South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, UK.

Classifications MeSH